Chapter review

Fitzgerald PMHNP board review. ch11. Substance-related Disorders. This is drive 3 of 8. When I say Pause. Answer. wait, then I will give the answer. New section. DSM-5-TR Diagnostic Criteria (Table 11-3). Topic. SUD Severity Specifiers. Bottom Line. * **Substance use disorder** requires meeting at least 2 out of 11 diagnostic criteria within a 12-month timeframe. * **Mild severity** is specified when a patient meets 2 to 3 diagnostic criteria. * **Moderate severity** is specified when a patient meets 4 to 5 diagnostic criteria. * **Severe severity** is specified when a patient meets 6 or more diagnostic criteria. * **Early remission** applies when no criteria are met, except craving, for at least 3 months but less than 12 months. * **Sustained remission** applies when no criteria are met, except craving, for 12 months or longer. * **DSM-5-TR** eliminated the previous DSM-IV distinction between substance abuse and substance dependence, combining them into a single diagnostic continuum. * Chronic substance use alters brain circuits in the **mesolimbic dopamine circuit**, creating persistent neural changes that can endure long after detoxification. Must Know for Boards. * Timeframe rule: All criteria must occur within the same 12-month period to establish a diagnosis of **substance use disorder**. * Diagnostic domains: The 11 criteria span 4 clinical clusters, including impaired control, social impairment, risky use, and pharmacological criteria. * Impaired control criteria: Taking larger amounts or over longer periods than intended, persistent desire or unsuccessful attempts to cut down, spending excessive time obtaining, using, or recovering, and intense craving. * Social impairment criteria: Failure to fulfill major role obligations at work, school, or home, continued use despite social or interpersonal problems, and giving up important activities. * Risky use criteria: Recurrent use in physically hazardous situations and continued use despite knowing a physical or psychological problem is caused or worsened by the substance. * Pharmacological criteria: Physiological tolerance and physical withdrawal. * Special exception rule: Tolerance and withdrawal criteria are not counted when a patient takes medications such as opioids or benzodiazepines under appropriate medical supervision. * Contextual specifiers: Clinicians must document if a patient is **in a controlled environment** or **on maintenance therapy** with agents like **methadone**, **buprenorphine**, or **naltrexone**. Diagnostic Criteria and Severity Architecture. Table 11-3 in Fitzgerald Chapter 11 outlines the DSM-5-TR diagnostic framework for **substance use disorder**. The classification evaluates 11 specific clinical criteria across cognitive, behavioral, and physiological domains. Rather than treating abuse and dependence as separate conditions, the modern framework places all substance use pathology on a single continuous spectrum. Severity is determined by counting the total number of positive criteria present over a 12-month period. Meeting 2 to 3 criteria establishes a classification of **mild severity**. Meeting 4 to 5 criteria establishes a classification of **moderate severity**. Meeting 6 or more criteria establishes a classification of **severe severity**. Diagnostic specifiers also define the course of recovery. Remission is tracked by time elapsed without meeting criteria, with craving permitted as the sole exception. Resolution lasting between 3 and 12 months is specified as **early remission**. Resolution lasting 12 months or longer is specified as **sustained remission**. Additional specifiers indicate if care occurs **in a controlled environment** where substance access is restricted or if the patient is maintained **on maintenance therapy**. Exam Signposts. Safety Alert. * Persistent neurocircuitry changes in the **mesolimbic dopamine circuit**, **amygdala**, and **hippocampus** persist beyond physical detoxification, leaving patients vulnerable to rapid relapse when exposed to environmental cues or severe stress. Board Trap. * Do not select obsolete DSM-IV terms like substance abuse or substance dependence on current board exams. DSM-5-TR uses only **substance use disorder** with severity specifiers. * Do not count tolerance or withdrawal toward a **substance use disorder** diagnosis if the patient is taking prescribed medications under legitimate medical management. First-Line Approach. * Calculate the exact number of criteria met in the past 12 months to assign the correct severity specifier (**mild**, **moderate**, or **severe**). * Combine evidence-based pharmacotherapy such as **acamprosate** or **naltrexone** with structured psychosocial therapies like **motivational interviewing** and **cognitive behavioral therapy**. Board-Style Practice Questions. Question 1. A 24-year-old law student is referred for evaluation after receiving a driving under the influence charge. He reports drinking 6 beers per night to relax and states, "I do not think my beer drinking has anything to do with my grades, I really only have a couple of beers to unwind." He meets 3 DSM-5-TR criteria for **alcohol use disorder** over the past 12 months. Which severity specifier should the PMHNP document? A) Substance abuse B) Mild alcohol use disorder C) Moderate alcohol use disorder D) Severe alcohol use disorder Pause. Answer: B Quick Answer. The correct diagnosis is **mild alcohol use disorder** because the patient meets 3 diagnostic criteria within a 12-month period. Key Clue. The stem states that the patient meets 3 criteria over the past 12 months. Best Answer. B) Mild alcohol use disorder Why It Is Correct. Under DSM-5-TR criteria, severity is determined by criterion count over 12 months: 2 to 3 criteria indicate **mild severity**, 4 to 5 criteria indicate **moderate severity**, and 6 or more criteria indicate **severe severity**. Why the Other Choices Are Wrong. * A: Substance abuse is an outdated DSM-IV category that is no longer used in DSM-5-TR. * C: Moderate severity requires meeting 4 to 5 criteria. * D: Severe severity requires meeting 6 or more criteria. Test-Taking Pearl. Memorize the severity cutoff numbers for boards: 2 to 3 criteria is mild, 4 to 5 is moderate, and 6 or more is severe. Question 2. A 42-year-old patient with a history of **severe alcohol use disorder** has not met any diagnostic criteria for alcohol use disorder, except for occasional craving, for the past 5 months while living in the community. Which specifier is most appropriate for the PMHNP to record? A) In sustained remission B) In early remission C) In a controlled environment D) On maintenance therapy Pause. Answer: B Quick Answer. The correct specifier is **in early remission** because the patient has been free of criteria, except craving, for at least 3 months but less than 12 months. Key Clue. The patient has been free of diagnostic criteria for 5 months. Best Answer. B) In early remission Why It Is Correct. **Early remission** is specified when a patient who previously met criteria for a **substance use disorder** meets no criteria, except craving, for at least 3 months but less than 12 months. Why the Other Choices Are Wrong. * A: Sustained remission requires being criteria-free, except craving, for a minimum of 12 consecutive months. * C: In a controlled environment applies only when physical access to the substance is restricted, such as during inpatient hospitalization or incarceration. * D: On maintenance therapy applies when the patient is taking prescribed maintenance medications like **buprenorphine** or **methadone**. Test-Taking Pearl. Remember the timeline pivot: 3 to 12 months is early remission, while 12 months or longer is sustained remission. Question 3. A 34-year-old individual reports using prescription opioids in larger amounts than intended, spending most of the day obtaining opioids, failing to maintain employment, experiencing intense cravings, continuing use despite interpersonal conflicts, and experiencing physical withdrawal when attempting to stop. Symptoms have persisted for 14 months. How should the PMHNP classify the severity? A) Mild opioid use disorder B) Moderate opioid use disorder C) Severe opioid use disorder D) Opioid dependence Pause. Answer: C Quick Answer. The correct classification is **severe opioid use disorder** because the patient demonstrates 6 diagnostic criteria. Key Clue. The stem describes 6 distinct diagnostic criteria met over a 14-month timeframe. Best Answer. C) Severe opioid use disorder Why It Is Correct. Meeting 6 or more criteria within a 12-month period satisfies the threshold for **severe substance use disorder**. Why the Other Choices Are Wrong. * A: Mild severity requires 2 to 3 criteria. * B: Moderate severity requires 4 to 5 criteria. * D: Opioid dependence is obsolete DSM-IV terminology. Test-Taking Pearl. Count each criterion mentioned in the vignette: 6 or more criteria automatically equals severe. Active Recall. 1. How many criteria must a patient meet within 12 months to diagnose a **substance use disorder**? 2. What is the criterion count range required for a **moderate substance use disorder** specifier? 3. What is the minimum duration required without criteria, except craving, to specify **sustained remission**? 4. Which two historical DSM-IV diagnostic terms were combined into **substance use disorder** in DSM-5-TR? 5. Which single criterion is allowed to persist during both **early remission** and **sustained remission**? Next Study Step. The single best next topic to review is **Alcohol Use Disorder Screening, Laboratory Findings, and BAC Effects** (Fitzgerald Chapter 11, Tables 11-4 through 11-7). Reviewing objective lab markers like elevated **AST**, **ALT**, **MCV**, and **triglycerides** directly reinforces the clinical assessment of substance severity. Next. Topic. The 'Tempted With Cocaine, Scotch, Rum' Mnemonic. Bottom Line Summary. * Diagnosis of **substance use disorder** under DSM-5-TR requires meeting at least 2 out of 11 diagnostic criteria within a 12-month period. * The memory tool **Tempted With Cocaine, Scotch, Rum** maps the 11 criteria into 5 clinical domains: **Tolerance**, **Withdrawal**, **Control** impairment, **Social** consequences, and **Risky** use. * Severity is coded by symptom count: **mild** is 2 to 3 criteria, **moderate** is 4 to 5 criteria, and **severe** is 6 or more criteria. * Remission specifiers require time thresholds: **early remission** means 3 to 12 months without meeting criteria (except craving), while **sustained remission** means 12 months or longer. * DSM-5-TR eliminated the former DSM-IV distinction between **substance abuse** and **substance dependence**, combining them into a single diagnostic continuum. * Substance use disorder creates long-lasting neurochemical and structural changes in the mesolimbic dopamine pathway that persist well past acute detoxification. DSM-5-TR Diagnostic Criteria and Mnemonic Breakdown. Core Diagnostic Framework (Table 11-3). Substance use disorder is a cluster of cognitive, behavioral, and physiological symptoms demonstrating that the individual continues using the substance despite significant substance-related problems. Fitzgerald highlights the mnemonic **Tempted With Cocaine, Scotch, Rum** to recall the 11 diagnostic criteria across 5 key categories. Mnemonic Category Breakdown. 1. **Tolerance** and **Withdrawal** (Tempted With) * **Tolerance**: Needing markedly increased amounts of the substance to achieve intoxication or desired effect, or experiencing a markedly diminished effect with continued use of the same amount. * **Withdrawal**: Experiencing the characteristic physiological withdrawal syndrome for the specific substance, or taking the substance (or a closely related substance) to relieve or avoid withdrawal symptoms. 2. **Control** Impairment (Cocaine) * Using larger amounts of the substance or over a longer period than was originally intended. * Persistent desire or unsuccessful efforts to cut down or control substance use. * Spending an excessive amount of time in activities necessary to obtain the substance, use the substance, or recover from its effects. * **Craving**: Experiencing a strong desire or urge to use the substance. 3. **Social** Consequences (Scotch) * Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home. * Continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance. * Important social, occupational, or recreational activities are given up or reduced because of substance use. 4. **Risky** Use (Rum) * Recurrent substance use in situations in which it is physically hazardous (such as driving while impaired). * Substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. Severity and Remission Specifiers. * **Mild**: Presence of 2 to 3 symptoms. * **Moderate**: Presence of 4 to 5 symptoms. * **Severe**: Presence of 6 or more symptoms. * **Early Remission**: No criteria met for at least 3 months but less than 12 months (with the exception of craving). * **Sustained Remission**: No criteria met at any time during a period of 12 months or longer (with the exception of craving). * **Additional Specifiers**: **In a controlled environment** (where access to the substance is restricted) and **On maintenance therapy** (such as agonist or partial agonist therapy for **opioid use disorder**). Clinical Practice Signposts. * **Safety alert**: **Physical dependence** (tolerance and withdrawal) can occur as a normal physiological adaptation to prescribed medications (such as long-term opioid therapy for pain or benzodiazepines for medical conditions) without the patient having a **substance use disorder**. Never diagnose a substance use disorder based solely on tolerance and withdrawal when medications are taken strictly under appropriate medical supervision. * **Board trap**: Confusing **substance dependence** with **physical dependence**. Test writers love to present a patient on prescribed maintenance therapy or pain management who exhibits tolerance, then ask for the diagnosis. If there is no compulsive use, loss of control, or social impairment, it is not a **substance use disorder**. * **First-line**: When evaluating a patient for potential substance use disorder, open-ended screening questions (such as "How much alcohol do you drink in a typical week?") combined with **motivational interviewing** are the initial non-judgmental steps to explore ambivalence and overcome **denial**. Board-Style Sample Practice Questions. Question 1. Marcus, a 24-year-old student at risk for failing out of law school, is referred by his academic advisor for psychiatric evaluation. He states that he drinks an average of six beers per night, and last year he had a driving under the influence (DUI) arrest. Marcus states, "I don't think my beer drinking has anything to do with my bad grades. I really only have a couple of beers every night, and it helps me to relax." This statement is an example of: * A. Enabling * B. Projection * C. Psychological dependence * D. Denial Pause. Answer: D Why It Is Correct. Marcus is demonstrating **denial**, the primary cognitive defense mechanism in **substance use disorders** where the patient minimizes the amount consumed (claiming "a couple" when actually drinking six) and refuses to acknowledge that substance use is causing his academic failure and legal problems. Why the Other Choices Are Wrong. * A: Enabling describes behaviors by family, friends, or caregivers that protect the substance user from experiencing the natural consequences of their behavior. * B: Projection is an unconscious defense mechanism where a person attributes their own unacknowledged, unacceptable thoughts or impulses onto someone else. * C: Psychological dependence involves emotional cravings and using a substance to regulate unpleasant mood states, whereas Marcus's statement specifically illustrates cognitive minimization of impairment. Test-Taking Pearl. When a question stem describes a patient downplaying consumption or refusing to connect substance use to clear job, school, or legal trouble, the board is testing recognition of **denial**. Question 2. The PMHNP response to Marcus that best illustrates **motivational interviewing** would be: * A. Relaxing is important to you after you have worked hard at school. * B. Do you see your DUI as an indication that you likely have a problem with alcohol? * C. Your advisor obviously thinks that your beer drinking is affecting your grades, and that is why he referred you here. * D. What else could be causing your low grades then? Pause. Answer: A Why It Is Correct. Option A utilizes reflective listening and empathy, acknowledging the patient's underlying desire ("relaxing is important to you") without arguing or imposing judgment. This core **motivational interviewing** technique reduces defensiveness and helps the patient explore their own ambivalence. Why the Other Choices Are Wrong. * A: Correct option. * B: Directly confronts the patient about his DUI, which escalates resistance and drives the patient deeper into **denial**. * C: Shifts blame to the academic advisor and creates an adversarial provider-patient relationship. * D: Uses a challenging, sarcastic tone that forces the patient to defend his position rather than examine his drinking behavior. Test-Taking Pearl. On board exams, correct **motivational interviewing** responses express empathy, roll with resistance, and reflect the patient's feelings without using confrontation, judgment, or advice-giving. Question 3. Strategies to prevent relapse among patients with **substance use disorders** include all of the following EXCEPT: * A. Relaxation techniques to address increased craving * B. Confront drug-using peers for closure * C. Social skills training * D. Give positive feedback for sustained abstinence, even with relapse Pause. Answer: B Why It Is Correct. Relapse prevention requires avoiding drug-using peers, avoiding environmental triggers, and developing refusal skills. Seeking out and confronting former drug-using peers creates intense interpersonal stress and exposure to substance cues, which significantly increases relapse risk. Why the Other Choices Are Wrong. * A: Learning relaxation techniques helps manage autonomic hyperarousal and internal craving triggers. * B: Correct choice as the exception. * C: Social skills training builds interpersonal assertiveness and helps patients handle peer pressure without using substances. * D: Providing positive reinforcement for periods of sobriety maintains engagement in treatment and encourages recovery even if a temporary slip occurs. Test-Taking Pearl. Always watch for negative stem modifiers like EXCEPT or LEAST. Effective relapse prevention focuses on stimulus control (avoiding high-risk people, places, and things) rather than confronting triggers directly. 💡 **Next Study Step**: Proceed to **Alcohol Use Disorder Screening, Laboratory Findings, and BAC Effects (Table 11-4 and Table 11-5)** to master objective lab markers (such as AST to ALT ratios and macrocytosis) and standardized screening instruments like CAGE and AUDIT. Next. New section. Alcohol Drinking Patterns (Table 11-7). Topic. Definition of a 'Standard Drink'. Bottom Line Summary. * A **standard drink** in the United States contains 12 g of pure ethanol (0.5 oz of pure alcohol). * Standard drink equivalents include 12 oz of regular beer (5% alcohol), 4 oz of non-fortified wine (12% alcohol), or 1 to 1.5 oz of 80-proof distilled spirits (40% alcohol). * The legal blood alcohol concentration (**BAC**) limit for operating a motor vehicle in the United States is 0.08 g/dL. * **Binge drinking** brings the **BAC** to 0.08 g/dL or higher, typically requiring 5 or more drinks for men or 4 or more drinks for women within a 2-hour window. * **Heavy drinking** is defined as 2 or more drinks per day for men (14 or more per week) or 1 or more drinks per day for women (7 or more per week). * **Moderate drinking** is defined as 2 or fewer drinks per day for men and 1 or fewer drinks per day for women, while adults over age 65 should consume less than 1 drink per day regardless of gender. * First-line craving reduction for **alcohol use disorder** includes **naltrexone** (opioid antagonist) or **acamprosate** (GABA and glutamate modulator). Must Know for Boards. Standard Drink Equivalents and BAC Parameters. A **standard drink** provides 12 g of pure ethanol (0.5 oz of pure alcohol). Test items evaluate whether you can calculate actual alcohol exposure based on drink volume and proof: * 12 oz of regular beer (5% alcohol content) * 4 oz of non-fortified wine (12% alcohol content, 24 to 28 proof) * 1 to 1.5 oz of liquor or distilled spirits (80 proof or 40% alcohol content) Comparing these beverage types shows that volume varies inversely with alcohol concentration: 12 oz of beer, 4 oz of wine, and 1.5 oz of liquor all deliver the exact same 12 g of ethanol. The legal **BAC** threshold for driving under the influence in the United States is 0.08 g/dL. **BAC** accumulation depends on biological sex, body weight, rate of consumption, and stomach emptying time. Peak **BAC** occurs within 30 to 90 minutes after ingestion, averaging 45 to 60 minutes on an empty stomach. Alcohol Drinking Patterns. Grouping drinking patterns highlights specific consumption thresholds across demographic populations: * **Binge drinking**: A acute pattern that elevates **BAC** to 0.08 g/dL or above within 2 hours. This corresponds to 5 or more standard drinks on a single occasion for men, or 4 or more standard drinks for women. * **Heavy drinking**: A chronic daily pattern defined as 2 or more drinks per day for men, or 1 or more drinks per day for women. * **Moderate drinking**: Daily maintenance defined as 2 or fewer drinks per day for men, or 1 or fewer drinks per day for women. * **Geriatric threshold**: For adults aged 65 and older, recommended consumption drops to less than 1 drink per day for both men and women due to age-related reductions in total body water and decreased hepatic drug metabolism. Clinical Signposts. * **Safety alert**: Impaired driving at or above a **BAC** of 0.08 g/dL poses severe safety hazards. If an intoxicated patient insists on driving from the clinic, immediate intervention and law enforcement notification are required to prevent harm. * **Board trap**: Assuming 1 container equals 1 standard drink. A 24 oz "tall boy" beer equals 2 standard drinks, and high-proof liquor delivers a far denser ethanol load per fluid ounce. Another trap is prescribing **naltrexone** to a patient with acute hepatitis or liver failure; **acamprosate** is the correct choice because it undergoes renal excretion. * **First-line**: **Naltrexone** or **acamprosate** combined with psychosocial counseling serves as first-line pharmacotherapy for moderate to severe **alcohol use disorder**. Compare and Distinguish. Binge Drinking vs. Heavy Drinking. * Think: Binge drinking is single-occasion volume; heavy drinking is daily chronic volume. * Priority: Binge drinking drives acute intoxication, trauma, and overdose risk. Heavy drinking drives organ damage, macrocytosis, and physical dependence. * Boards are testing: Gender-specific thresholds. Binge is 5+ drinks (men) or 4+ drinks (women) in 2 hours. Heavy is 2+ drinks/day (men) or 1+ drink/day (women). Naltrexone vs. Acamprosate. * Think: Naltrexone blocks the reward high; acamprosate balances post-withdrawal brain chemistry. * Priority: Check liver function and opioid use history before picking a medication. * Boards are testing: Clearance pathways. **Naltrexone** is hepatically metabolized and contraindicated in liver failure or active opioid use. **Acamprosate** is renally excreted, making it safe in liver disease but contraindicated in severe renal failure. Sample Board Practice Questions. Question 1. Marcus, a 24-year-old law student at risk of failing out of school, is referred for psychiatric evaluation following a driving under the influence arrest. Marcus states, "I do not think my beer drinking has anything to do with my bad grades. I really only have a couple of beers every night, and it helps me to relax." This statement represents which defense mechanism? * A. Enabling * B. Projection * C. Psychological dependence * D. Denial Pause. Answer: D. Why it is correct: Denial is the primary cognitive defense mechanism in **substance use disorders** where the patient minimizes consequences, insists drinking causes no impairment, and denies the need for treatment. Why the other choices are wrong: * A. Enabling refers to actions by family or peers that inadvertently shield the user from consequences. * B. Projection involves attributing one's own unacceptable feelings onto another person. * C. Psychological dependence describes emotional cravings and using alcohol to regulate mood, whereas minimizing life impairment is denial. Question 2. Gary, a 54-year-old man with moderate liver disease, has a history of **alcohol use disorder** and has maintained sobriety for 3.5 years. Following the death of his sibling and job loss, he reports severe alcohol cravings. To prevent relapse, the PMHNP recommends counseling and pharmacotherapy with: * A. Acamprosate * B. Naloxone * C. Clonidine * D. Lorazepam Pause. Answer: A. Why it is correct: **Acamprosate** reduces alcohol cravings by modulating GABA and glutamate transmission. Because it is renally excreted, it is safe for patients with underlying liver disease. Why the other choices are wrong: * B. Naloxone is an emergency opioid overdose reversal agent (Narcan) with no role in alcohol relapse prevention. * C. Clonidine is an alpha-2 agonist used to manage autonomic hyperactivity during acute withdrawal, not for long-term craving reduction. * D. Lorazepam is a benzodiazepine used for acute detoxification, not long-term relapse prevention. Question 3. Randy, a 32-year-old manager, presents for follow-up 45 days after completing inpatient rehabilitation for alcohol dependence. He remains abstinent but experiences daily alcohol cravings. Which medication is most appropriate to target his cravings? * A. Disulfiram * B. Bupropion * C. Naltrexone * D. Naloxone Pause. Answer: C. Why it is correct: **Naltrexone** is a mu-opioid receptor antagonist that blocks endogenous opioid release, eliminating the reinforcing euphoric high of alcohol and reducing cravings. Why the other choices are wrong: * A. Disulfiram is an aversion therapy that causes a toxic reaction if alcohol is consumed, but it does not directly modulate cravings. * B. Bupropion is a dopamine-norepinephrine reuptake inhibitor used for depression and smoking cessation, not alcohol cravings. * D. Naloxone is a short-acting emergency opioid antagonist used for overdose reversal, not chronic alcohol craving management. Question 4. Dana, a 44-year-old nurse, is preparing for discharge from a 30-day treatment program for **alcohol use disorder**. She requests medication to support abstinence. She is scheduled for extensive oral surgery requiring postoperative pain management next month. Which medication is contraindicated? * A. Disulfiram * B. Naltrexone * C. Acamprosate * D. Sertraline Pause. Answer: B. Why it is correct: **Naltrexone** blocks opioid receptors. Because Dana will require opioid analgesics following her upcoming surgery, naltrexone is contraindicated because it blocks pain relief and can trigger acute opioid withdrawal. Why the other choices are wrong: * A. Disulfiram inhibits aldehyde dehydrogenase and does not block opioid analgesics. * C. Acamprosate acts on GABA and glutamate, does not interfere with opioid pain medications, and is safe prior to surgery. * D. Sertraline is an SSRI antidepressant with no opioid receptor activity and no surgical contraindication. Next Study Step. Study **Fitzgerald Chapter 11: Assessment and Management of Alcohol Withdrawal (CIWA Scale and Benzodiazepine Protocols)** next. * **Why this is the best next step**: Moves logically from drinking patterns and screening into acute medical stabilization. * **What knowledge gap it closes**: Master the timing, scoring, and pharmacotherapy (chlordiazepoxide, diazepam, lorazepam) for acute alcohol detoxification. * **What confusion it helps prevent on boards**: Clearly separates acute detoxification agents (benzodiazepines) from post-detoxification relapse prevention drugs (**naltrexone**, **acamprosate**, **disulfiram**). 💡 *Want to quiz yourself on CIWA withdrawal scoring thresholds or explore the pharmacological differences between disulfiram and naltrexone next?* Next. Topic. Older Adult Drinking Guidelines. Fitzgerald Chapter 11: Older Adult Drinking Guidelines. Bottom Line Summary. * **Older adult drinking threshold**: For individuals aged 65 and older, national guidelines recommend consuming less than 1 standard drink per day (maximum of 1 drink daily) regardless of gender. * **Standard drink volume**: One standard drink contains 12 grams of pure ethanol, equal to 12 ounces of beer, 4 ounces of non-fortified wine, or 1.5 ounces of 80-proof distilled spirits. * **Adult vs older adult contrast**: Under age 65, moderate drinking is up to 2 drinks daily for men and 1 drink daily for women. After age 65, gender differences disappear and the limit drops to less than 1 drink daily for all adults. * **Under-screening population**: Older adults, women, and adolescents represent the three patient groups most frequently under-screened for alcohol use disorder. * **Physiological vulnerability**: Decreased total body water, reduced hepatic metabolism, and heightened central nervous system sensitivity cause older adults to achieve higher blood alcohol concentrations from smaller amounts of alcohol. * **First-line pharmacotherapy in liver impairment**: **Acamprosate** is the primary choice for maintaining abstinence in older adults or patients with liver disease because it is renally excreted, whereas **naltrexone** is contraindicated in acute hepatitis or liver failure. * **High-risk withdrawal predictor**: A prior history of **delirium tremens** or withdrawal seizures is the single most prominent factor requiring inpatient hospitalization for alcohol detoxification. Core Spoken Teaching: Alcohol Drinking Patterns and Older Adult Guidelines. Evaluating alcohol consumption requires understanding standard drink definitions, gender-based daily limits, and age-specific physiological considerations. A standard drink delivers 12 grams of ethanol. This is equivalent to: * 12 ounces of beer * 4 ounces of non-fortified wine * 1.5 ounces of 80-proof hard liquor The legal blood alcohol concentration limit for operating a motor vehicle in the United States is 0.08 grams per deciliter. Drinking patterns in younger adults are categorized as follows: * **Moderate drinking**: Up to 2 drinks per day for men, and up to 1 drink per day for women under age 65. * **Heavy drinking**: 2 or more drinks per day for men, or 1 or more drinks per day for women. * **Binge drinking**: Consuming 5 or more drinks for men, or 4 or more drinks for women, on a single occasion within approximately 2 hours, bringing blood alcohol concentration to 0.08 grams per deciliter or higher. Older Adult Specific Guidelines. For adults over 65 years of age, guidelines recommend consuming less than 1 drink per day for both men and women. **Safety alert**: Aging reduces total body water volume and hepatic enzyme activity. As a result, an older adult consuming a single drink will achieve a significantly higher blood alcohol concentration and experience greater cognitive and motor impairment than a younger person drinking the same amount. **Board trap**: Test-takers often apply standard gender-based thresholds (2 drinks for men, 1 for women) to elderly vignettes. On board exams, remember that gender distinction drops away after age 65; the limit is less than 1 drink daily for both male and female older adults. **First-line**: Screen every older adult using open-ended questions. Ask "How much alcohol do you drink?" rather than "Do you drink alcohol?" Older adults, women, and adolescents are the three groups most under-screened in primary and psychiatric care. Pharmacotherapy Selection in Older Adults. When managing alcohol use disorder in older adults or patients with medical comorbidities: * **Acamprosate**: **First-line** agent for maintaining abstinence in patients with liver disease. It restores GABA and glutamate balance and is excreted by the kidneys. * **Naltrexone**: Reduces cravings by blocking endogenous opioids. **Safety alert**: **Naltrexone** carries a risk of dose-dependent hepatotoxicity and is contraindicated in acute hepatitis or liver failure. It is also contraindicated if the patient requires opioid analgesics for scheduled surgeries. * **Disulfiram**: Aversive agent causing acetaldehyde buildup if alcohol is consumed. **Safety alert**: It is not initial therapy and is contraindicated in severe cardiac disease, significant hepatic impairment, or cognitive deficits. Fitzgerald Sample Practice Questions. Question 1. Gary, a 54-year-old man with moderate liver disease, has a history of alcohol use disorder but has been abstinent for the past 3.5 years. At this visit, he reports a number of unfortunate events that have happened recently, including the death of a close sibling and loss of employment. As a result, he states that he is having increased urges to drink again. To prevent a possible relapse, the PMHNP recommends counseling and treatment with which medication? * A) Acamprosate * B) Naloxone * C) Clonidine * D) Lorazepam Pause. Answer. **Best Answer**: A **Why It Is Correct**: **Acamprosate** maintains abstinence by balancing GABA and glutamate pathways. Because **acamprosate** is eliminated renally, it is safe for patients with moderate liver disease. **Why the Other Choices Are Wrong**: * A) Correct. * B) Naloxone is an acute opioid antagonist used to reverse opioid overdose, not an oral treatment for alcohol cravings. * C) Clonidine is an alpha-2 agonist that treats autonomic hyperactivity during acute withdrawal, not long-term craving or relapse prevention. * D) Lorazepam is a benzodiazepine used for acute detoxification; it carries addiction potential and does not treat underlying alcohol cravings. Question 2. Marcus, a 24-year-old student at risk for failing law school, is referred for evaluation after a DUI arrest. He states, "I don't think my beer drinking has anything to do with my bad grades. I really only have a couple of beers every night, and it helps me to relax." Which response by the PMHNP best illustrates motivational interviewing? * A) "Relaxing is important to you after you have worked hard at school." * B) "Do you see your DUI as an indication that you likely have a problem with alcohol?" * C) "Your advisor obviously thinks that your beer drinking is affecting your grades, and that is why he referred you here." * D) "What else could be causing your low grades then?" Pause. Answer. **Best Answer**: A **Why It Is Correct**: Motivational interviewing uses reflective listening and non-judgmental empathy to validate feelings and explore ambivalence without triggering defensive denial. **Why the Other Choices Are Wrong**: * A) Correct. * B) This response is direct and confrontational, which reinforces denial and increases resistance. * C) This response shifts focus to an outside authority, alienating the patient instead of building internal motivation. * D) This response sounds argumentative and forces the patient to defend their position. Question 3. Randy, a 32-year-old manager, is seen for follow-up 45 days after completing an inpatient stay for alcohol dependence. He remains sober but reports persistent, strong cravings for alcohol throughout the day. His liver function tests are completely normal. Which medication should be prescribed to target alcohol cravings? * A) Disulfiram * B) Bupropion * C) Naltrexone * D) Naloxone Pause. Answer. **Best Answer**: C **Why It Is Correct**: **Naltrexone** blocks endogenous opioid receptors, removing the pleasure associated with alcohol and reducing daily cravings in patients with normal liver function. **Why the Other Choices Are Wrong**: * A) Disulfiram is an aversion agent that causes physical illness if alcohol is consumed; it does not block cravings. * B) Bupropion is indicated for depression and smoking cessation, not alcohol craving reduction. * C) Correct. * D) Naloxone is a short-acting emergency overdose reversal agent, not an oral maintenance therapy. Question 4. Dana, a 44-year-old registered nurse, is preparing for discharge from an inpatient facility for alcohol dependence. She wishes to start medication to support abstinence. However, she has extensive oral surgery scheduled within the next month that will require prescription pain management. Which medication is contraindicated for this patient? * A) Disulfiram * B) Naltrexone * C) Acamprosate * D) Sertraline Pause. Answer. **Best Answer**: B **Why It Is Correct**: **Naltrexone** is an opioid receptor antagonist. Administering **naltrexone** to a patient who requires post-operative opioid analgesics will block pain relief and can precipitate acute opioid withdrawal. **Why the Other Choices Are Wrong**: * A) Disulfiram does not block opioid analgesics and is not contraindicated for upcoming surgery. * B) Correct. * C) Acamprosate does not act on opioid receptors and can be safely co-administered with prescription opioid analgesics. * D) Sertraline is an SSRI antidepressant that does not interfere with opioid pain management. Question 5. When deciding on the treatment setting to manage acute withdrawal symptoms for a 46-year-old man with a history of alcohol use disorder, which factor is most prominent in favoring inpatient hospitalization over outpatient detoxification? * A) A CIWA-Ar score of less than 15 * B) A history of alcohol use disorder for over two years * C) A history of major depressive disorder * D) A prior history of delirium tremens Pause. Answer. **Best Answer**: D **Why It Is Correct**: A history of **delirium tremens** or withdrawal seizures indicates a high risk for life-threatening complications, making inpatient medical admission mandatory. **Why the Other Choices Are Wrong**: * A) A CIWA-Ar score under 15 indicates mild to moderate withdrawal, which can be safely managed in outpatient settings. * B) Length of diagnosis alone does not determine admission level if current withdrawal is mild and uncomplicated. * C) Comorbid depression requires monitoring, but in the absence of active suicidality or severe physical withdrawal, outpatient care is appropriate. * D) Correct. Active Recall Checkpoints. 1. What is the recommended maximum daily alcohol intake limit for adults aged 65 and older? 2. Which three patient populations are most frequently under-screened for alcohol use disorder? 3. Why is **acamprosate** preferred over **naltrexone** in an older adult with alcohol use disorder and elevated liver transaminases? 4. What lab finding on a complete blood count serves as an objective marker for heavy alcohol consumption occurring over 2 to 3 months? 5. How do age-related changes in body composition alter blood alcohol concentration in older adults? Next Study Step. Study **Fitzgerald Chapter 11: Pharmacotherapy for Alcohol Dependence and Withdrawal Protocols (CIWA-Ar vs. COWS)** next. * **Why this is the best next step**: It builds directly on drinking definitions by mastering acute detoxification safety and long-term craving management. * **What knowledge gap it closes**: Clarifies exact dosing, lab monitoring, and contraindications between **naltrexone**, **acamprosate**, and **disulfiram**. * **What confusion it helps prevent on boards**: Prevents confusing acute withdrawal stabilization (benzodiazepines, thiamine) with post-detox maintenance therapy (**acamprosate**, **naltrexone**). 💡 Want to walk through the acute alcohol withdrawal CIWA protocol next, or should we drill active recall practice questions on liver lab markers (AST/ALT ratios and MCV)? Next. End of this drive.